Status:
COMPLETED
Small and Steatotic Hepatocellular Carcinoma
Lead Sponsor:
University Hospital, Montpellier
Conditions:
HCC
Eligibility:
All Genders
18+ years
Brief Summary
Percutaneous thermoablation in an effective local curative treatment in patients with cirrhosis and HCC smaller than 3 cm in diameter (BCLC 0-A). Around 30% of HCC patients referred for percutaneous ...
Detailed Description
We performed 412 percutaneous thermoablations on 238 patients for HCC between January 2015 and November 2019. All thermoablation procedures were performed percutaneously under ultrasound or CT guidan...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- HCC according to histological examination or Barcelona criteria
- BCLC0 or A
- Measurable targets according to mRECIST v1.1
- Child A or B7 cirrhosis
- HCC \< 4 cm, \< 3 nodules, Age ≥ 18 years
- No extrahepatic metastasis, no vascular invasion
- Performance status 0 or 1
- Thrombocytes ≥ 50 000/mm3, TP \> 50%
- Exclusion criteria:
- Follow-up \< 1month
- Lobar/main portal venous thrombus
- Abundant ascites
- Antecedent of bilio-digestive anastomosis or endoscopic sphincterotomy
- Combined treatment with embolization or chemo-embolization
Exclusion
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
238 Patients enrolled
Trial Details
Trial ID
NCT03428321
Start Date
January 1 2015
End Date
December 30 2019
Last Update
May 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295